COMMUNIQUÉS West-GlobeNewswire

-
Novo Nordisk A/S – Share repurchase programme
30/09/2019 -
Generex Biotechnology Subsidiary Olaregen Therapeutix Signs National Sales & Distribution Agreement With AvKare Medical to Distribute Excellagen® Throughout the VA Hospital System
30/09/2019 -
Innovation Pharmaceuticals Engages Locust Walk, A Global Life Sciences Transaction Firm
30/09/2019 -
Digipath to Acquire Cannabis Technology Firm VSSL Enterprises Ltd.
30/09/2019 -
Albireo Announces Presentations at NASPGHAN 2019 Annual Meeting
30/09/2019 -
CK Hutchison prices offering of Chi-Med share capital enabling deconsolidation and confirms its intention to hold Chi-Med as a strategic investment for the long term
30/09/2019 -
Flexion Therapeutics to Present at the 2019 Cell & Gene Meeting on the Mesa
30/09/2019 -
BioNovelus, Inc. Announces Letter of Intent to Purchase Corvus Consulting, LLC
30/09/2019 -
Executive Women In Bio Selects Chapter Leaders to Amplify Community Building and Facilitate Program Expansion for Executive Members
30/09/2019 -
Transactions under Novozymes’ stock buyback program
30/09/2019 -
Homology Medicines to Participate in Conferences in October
30/09/2019 -
Clear Benefit for Patients with Synovial Sarcoma Demonstrated in Updated Data from Ongoing Phase 1 Trial with ADP-A2M4 Presented at ESMO
30/09/2019 -
Golden Leaf Holdings Announces California Expansion
30/09/2019 -
Acasti Pharma Announces Additional Phase 3 Milestones Reached, and Remains on Track to Report Topline Results for TRILOGY 1 in December 2019 and TRILOGY 2 in January 2020
30/09/2019 -
Sharps Compliance Adds Susan Vogt to Board of Directors
30/09/2019 -
Turning Point Therapeutics Announces FDA Clearance of Investigational New Drug Application for TPX-0046, a Novel RET/SRC Inhibitor
30/09/2019 -
Ultragenyx and Kyowa Kirin Announce U.S. FDA Approves Label Update for Crysvita® (burosumab) for the Treatment of X-Linked Hypophosphatemia (XLH)
30/09/2019 -
Immunoscore to support Immuno-oncology and microbiome research within the ONCOBIOME consortium
30/09/2019 -
Teneobio Licenses Oncology Multispecific Product to Janssen
30/09/2019
Pages